Kopran Profit & Loss Annual

BSE: 524280 | NSE: KOPRAN | ISIN: INE082A01010 | Sector: Biotechnology & Drugs

220.55 +0.95 (0.43%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	614.59	550.99	477.52	491.81
Total Revenue	614.59	550.99	477.52	491.81
Costof Revenue Total	401.94	388.14	295.84	324.43
Gross Profit	212.65	162.85	181.69	167.38
Selling/ General/ Admin Expenses Total	52.28	100.49	91.09	82.56
Depreciation/ Amortization	12.89	12.71	11.10	10.19
Other Operating Expenses Total	85.95	4.36	2.58	2.22
Total Operating Expense	553.07	505.70	400.60	419.41
Operating Income	61.53	45.28	76.92	72.41
Interest Inc( Exp) Net- Non- Op Total	-14.23	-82.63	51.76	118.71
Other Net	7.44	-0.95	-0.31	-0.82
Net Income Before Taxes	67.54	36.07	81.78	83.34
Provisionfor Income Taxes	16.59	8.83	20.75	21.73
Net Income After Taxes	50.96	27.23	61.03	61.61
Net Income Before Extra Items	50.96	27.23	61.03	61.61
Net Income	50.96	27.23	61.03	61.61
Income Availableto Com Excl Extra Ord	50.96	27.23	61.03	61.61
Income Availableto Com Incl Extra Ord	50.96	27.23	61.03	61.61
Diluted Net Income	50.96	27.23	61.03	61.61
Diluted Weighted Average Shares	4.83	4.82	4.43	4.33
Diluted EPS Excluding Extra Ord Items	10.55	5.65	13.77	14.24
DPS- Common Stock Primary Issue	3.00	3.00	3.00	3.00
Diluted Normalized EPS	10.55	5.65	13.77	14.26
Unusual Expense( Income)	-	0.00	0.00	0.00
Gain( Loss)on Saleof Assets	-	0.00	0.00	-1.20